Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Novo said the trial suggests the drug is safe and has a similar side effect ... potentially worth as much as $100 billion or more by the end of the decade. Novo, along with another diabetes ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

Novo Nordisk has lifted the lid on a phase 1 trial of its oral amylin and GLP-1 receptor co-agonist, linking the candidate to ...

As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics ...

Along with NASH, Novo Nordisk is also planning to investigate the drug's activity in chronic kidney ... with preclinical-stage candidate IC 100 that is being considered for multiple sclerosis.

(Image Credits: Pixabay) Novo Nordisk‘s experimental weight-loss pill amycretin was safe and tolerable ... DNA Wellness to invest Rs 200 Cr to set up 100 DNA Ploidy Test labs for cervical ...

Novo Nordisk is working to resolve supply issues that are affecting the launch of its weight-loss and diabetes medications, ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...